Literature DB >> 7388758

Causes of death in breast cancer: a clinicopathologic study.

F B Hagemeister, A U Buzdar, M A Luna, G R Blumenschein.   

Abstract

Between January 1973 and October 1977, 166 patients who died of breast cancer were autopsied. The examination revealed consistently more tumor involvement than had been clinically suspected. Unsuspected areas of tumor involvement included the endocrine organs (40%), lungs (28%), cardiovascular system (21%), and the genitourinary system (21%). The error in diagnosis was smaller with metastasis to the bones (10%) and central nervous system (14%). The major causes of death included pulmonary insufficiency (26%), infection (24%), cardiac disease (15%), hepatic insufficiency (14%), hemorrhage (9%), central nervous system disease (9%), and hypercalcemia (3%). The most common cause of death was metastatic disease to various organs, accounting for 42% of all deaths. Infection was the second most common cause of death; however, only 27% of the patients with infection had significant neutropenia. In patients dying of hemorrhage, only 9% were thrombocytopenic. In conclusion, although many clinicians have expressed concern that chemotherapy would add to early mortality in cancer, our study shows that this is not the case for patients with breast cancer. Deaths due to chemotherapy were rare and the rise in the infection rate did not correlate with the advent of chemotherapy.

Entities:  

Mesh:

Year:  1980        PMID: 7388758     DOI: 10.1002/1097-0142(19800701)46:1<162::aid-cncr2820460127>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

Review 1.  Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?

Authors:  Ana Sofia Azevedo; Gautier Follain; Shankar Patthabhiraman; Sébastien Harlepp; Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2015-08-27       Impact factor: 3.405

Review 2.  Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.

Authors:  Iain L O Buxton; Nucharee Yokdang; Robert M Matz
Journal:  Cancer Lett       Date:  2010-05-28       Impact factor: 8.679

Review 3.  siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion.

Authors:  Worapol Ngamcherdtrakul; Wassana Yantasee
Journal:  Transl Res       Date:  2019-08-19       Impact factor: 7.012

4.  Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors.

Authors:  Xujuan Yang; Aashvini Belosay; James A Hartman; Huaxin Song; Yukun Zhang; Wendan Wang; Daniel R Doerge; William G Helferich
Journal:  Clin Exp Metastasis       Date:  2015-03-08       Impact factor: 5.150

Review 5.  Patterns of metastasis and natural courses of breast carcinoma.

Authors:  Y T Lee
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

6.  Selection of more aggressive variants of the gI101A human breast cancer cell line: a model for analyzing the metastatic phenotype of breast cancer.

Authors:  Dina Chelouche Lev; Galina Kiriakova; Janet E Price
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

7.  Estradiol increases ER-negative breast cancer metastasis in an experimental model.

Authors:  Xujuan Yang; Aashvini Belosay; Mengyuan Du; Timothy M Fan; Russell T Turner; Urszula T Iwaniec; William G Helferich
Journal:  Clin Exp Metastasis       Date:  2013-10-05       Impact factor: 5.150

Review 8.  Novel treatment strategies for brain tumors and metastases.

Authors:  Salma E El-Habashy; Alaa M Nazief; Chris E Adkins; Ming Ming Wen; Amal H El-Kamel; Ahmed M Hamdan; Amira S Hanafy; Tori O Terrell; Afroz S Mohammad; Paul R Lockman; Mohamed Ismail Nounou
Journal:  Pharm Pat Anal       Date:  2014-05

9.  Breast cancer and thoracic metastases: review of 119 patients.

Authors:  H Kreisman; N Wolkove; H S Finkelstein; C Cohen; R Margolese; H Frank
Journal:  Thorax       Date:  1983-03       Impact factor: 9.139

10.  Pericardial effusion complicating breast cancer.

Authors:  P J Woll; R K Knight; R D Rubens
Journal:  J R Soc Med       Date:  1987-08       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.